key: cord-1047365-qlxog5c4
authors: Paczkowska, Anna; Hoffmann, Karolina; Raakow, Jonas; Pross, Matthias; Berghaus, Rafael; Michalak, Michał; Bryl, Wiesław; Marzec, Kinga; Kopciuch, Dorota; Zaprutko, Tomasz; Ratajczak, Piotr; Nowakowska, Elżbieta; Kus, Krzysztof
title: Impact of bariatric surgery on depression, anxiety and stress symptoms among patients with morbid obesity: international multicentre study in Poland and Germany
date: 2022-01-25
journal: BJPsych Open
DOI: 10.1192/bjo.2021.1084
sha: c387172798726a00df93d89370a9b8cff2fa1102
doc_id: 1047365
cord_uid: qlxog5c4

BACKGROUND: There is a need to investigate how adopting different strategies for treating obesity in different countries in the European Union affects the psychological well-being of patients. AIMS: The aim of this study was to perform a comparative evaluation of psychiatric symptoms (depression, anxiety and stress) in patients undergoing bariatric surgery versus patients receiving conservative treatment for morbid obesity in Poland and Germany. METHOD: A multicentre international prospective cohort study with 155 patients who underwent bariatric surgery and 409 patients who received conservative weight reduction treatment. Evaluation of the psychiatric symptoms was carried out for each patient at baseline and after 12 months of active treatment using a standardised Depression Anxiety Stress Scale questionnaire (DASS-21) questionnaire. RESULTS: After 12 months of active treatment, the level of psychiatric symptoms (depression, anxiety and stress) significantly decreased in both groups of patients: surgically treated versus conservatively treated patients from Poland and also from Germany. The median change in level of psychiatric symptoms among patients from both countries was significantly higher among surgically treated patients compared with conservatively treated patients (Poland P < 0.0001; Germany P < 0.0001). Improvements in the patient's mental health as a consequence of treatment were dependent on the specific strategy for treating obesity adopted in the analysed countries, the percentage of total weight loss and on gender. CONCLUSIONS: The use of bariatric surgery in both Poland and Germany compared with non-surgical treatment for obesity resulted in more measurable benefits in the form of a decrease in psychiatric symptoms (depression, anxiety and stress) and reduction in body weight.

Many studies have shown that obesity is associated with a psychopathological burden, and has a negative impact on health-related quality of life. 1 Meta-analyses have shown cross-cultural differences in the relationship between obesity and mental health. The associations among psychological predictors are related to lower family affluence, self-assessed attractiveness, gender, health policy, life satisfaction and socioeconomic conditions. 2 Many studies have shown that bariatric surgery compared with non-surgical treatment for obesity leads to more significant weight loss and higher remission of comorbidities. 3, 4 Moreover, some studies indicate that bariatric surgery is generally associated with improved mental health and quality of life and even improvement in the patient's financial situation. 5 The effect of bariatric surgery on health, including psychological aspects, has been analysed by a few scientists, including Borgeraas et al. 6 Although bariatric surgery is generally effective, there is great variability in outcome. 7 The significant predictors influencing improvement in patients' mental health as a result of bariatric surgery include the type of bariatric surgery performed, weight loss, medical comorbidity and social support. It is also likely that pre-existing and post-surgical physical, psychological and social factors interact with weight loss to influence improvements in mental health following bariatric surgery. 8, 9 In a study by Picot et al improvement in mental health was greater in people who underwent laparoscopic sleeve gastrectomy and gastric bypass surgery compared with laparoscopic adjustable gastric banding (1 year) and vertical banding gastroplasty (2 years) . This may be because these procedures result in greater weight loss in this time period. 10 In Poland, the influence of bariatric surgery on the psychological behaviour of patients has not yet been thoroughly investigated. Moreover, the literature lacks international comparisons of the effectiveness of the obesity treatment strategies adopted in individual countries. So far, a study conducted by Genco et al 11 showed differences in clinical efficacy and patient satisfaction with bariatric surgery in three European countries (Italy, Belgium and Spain). Psychosocial variables as well as the availability of psychiatric and psychological support predict weight loss or mental health after obesity surgery. 12 Interesting findings come from a Portuguese case-control study, which aimed to assess the impact of social support on the final outcome of bariatric surgery. The authors confirmed that perceived stronger social support was associated with better mental health and greater weight loss in both the pre-and post-operative groups. 13 A meta-analysis by Dawes et al revealed that there was conflicting evidence on the association between preoperative psychopathology and post-operative weight loss. 14 There is also insufficient scientific data to assess the impact the type of bariatric surgery undergone has on patients' mental health. Thus, as the number of patients undergoing bariatric surgery increases in high-income countries (such as Poland and Germany), so does the need to investigate how psychiatric symptoms may influence the results of bariatric surgery compared with conservative treatment for obesity.

Moreover, the obesity treatment strategy developed by the German healthcare system differs significantly from that developed in Poland. In Germany, specialised obesity treatment health centres that offer comprehensive conservative treatment focus on four areas of intervention and application: advice on diet and training, movement therapy and exercise, psychoeducation and behavioural therapy interventions. 15 Whereas in Poland, the obesity treatment process is carried out as part of primary healthcare or in a few specialist out-patients obesity clinics. 16 There is a need to investigate how the strategy adopted for treating obesity in different countries of the European Union affects the psychological well-being of patients.

This study aimed to perform a comparative evaluation of the percentage of weight loss and changes in psychiatric symptoms (depression, anxiety and stress) in patients undergoing bariatric surgery versus non-surgical treatment (conservative treatment) for morbid obesity in Poland versus Germany.

A multicentre international prospective cohort study was conducted at four selective healthcare facilities in Germany and Poland. The target group of 564 patients consists of two groups of patients: patients undergoing bariatric surgery -155 patients (73 from Germany and 82 from Poland) and patients receiving conservative weight reduction treatment -409 patients (137 from Germany and 272 from Poland).

The inclusion criteria for both groups were: age ≥ 18 years; surgically or conservatively treated obesity in the study time horizonfrom 1 January 2019 to 31 December 2019; body mass index (BMI) ≥ 35 kg/m 2 associated with comorbidities; stable obese for at least 5 years; absence of illicit drugs or alcohol misuse; lack of moderate or severe psychosis or dementia; and patient's consent to participate in the study. Their attending physician decided to include a patient in the study based on the inclusion and exclusion criteria defined above.

Surgical or endoscopic procedures were performed using the German and Polish guidelines for bariatric surgery. 17, 18 In Germany, the conservative treatment offered was a 1-year multimodal out-patient weight reduction programme. This conventional out-patient weight reduction treatment consisted of four areas of intervention and application:

(a) advice on diet and training; (b) movement therapy and training; (c) psychoeducation; and (d) behavioural therapy interventions.

These interventions were conducted in group settings designed for eight to ten participants and were held twice a week for 2 h during the first 6 months and once weekly for 3 h during the second 6 months. This programme was led by a physician and clinical psychologist.

In Poland, the conservative treatment was carried out in a specialist obesity out-patient clinic. Conventional out-patient weight reduction treatment was led by a physician and dieticians who provided regular (on average once a month) individual medical consultations on the principles of proper nutrition, lifestyle changes, pharmacotherapy and the selection of an appropriate low-calorie diet.

Before the study, each eligible study participant was informed about the study objectives and conditions and gave their written informed consent to participate in the study. All procedures involving human patients were approved by the Ethics Committee of the Poznan University of Medical Sciences and by the Ethics Committee of the Charité -Universitätsmedizin Berlin.

Evaluation of the psychiatric symptoms (depression, anxiety and stress) in the participants who underwent bariatric surgery or conservative treatment for morbid obesity was carried out using a standardised Depression Anxiety Stress Scale questionnaire in Polish and German, version (DASS-21). 19 The DASS-21 is a 21item questionnaire that is commonly used as a tool for the assessment of the levels of self-perceived depression, anxiety and stress in participants aged 14 years and above. The DASS-21 was constructed as a shorter version of the DASS-42 questionnaire and has three main domains: depression, anxiety and stress. In each domain there are seven questions, with a Likert scale ranging from zero to three. Polish and German versions of this questionnaire were adequately translated with high validity and internal reliability. [20] [21] [22] During the 12 months of active treatment, each participant completed the questionnaires twice. Non-surgical patients in Germany completed the questionnaires before (at baseline) and after completing the 1-year multimodal out-patient weight reduction programme (the DASS-21 was administrated twice: on the first and last visit). The completion rate during the study time horizon was 96%. Similarly, non-surgical patients in Poland completed the questionnaires at baseline and after 1 year of regular medical and dietary visits. Among the surgical patients, the DASS-21 was administered 1 day before surgery (at baseline) and 1 year after their bariatric surgery.

In addition, specific information about patients was collected from medical records (the duration of the disease, the course of treatment to date, the presence of comorbidities). All the patients completed the questionnaires independently. Completed questionnaires (100% filled out by the patients) were included in the study analysis.

At the beginning and the end of the study, a physical examination was undertaken, and updated patient medical records were analysed. Weight, height and BMI was assessed in the whole study group at baseline and after the 12 months of active treatment. The weight in kilogram was analysed using electric scales (TANITA TBF-240, Arlington Heights, USA). Height was measured using a standard measuring rod, barefoot and in the Frankfort position.

To evaluate the efficacy of the treatments, we calculate %TWL (percentage of total weight loss) and %EWL (percentage of excess weight loss). The formulas proposed by Baltasar et al 23 were used to calculate the BMI, %TWL, and %EWL as follows: (c) %EWL: [ (initial weight − current weight)/ (initial weightideal weight)] × 100.

%EWL variables were created, with the ideal weight taken from the tables for the Polish 24 and Germany population. 25 

Results were analysed statistically. The quantitative parameters were presented using mean value, median and standard deviation. The results between analysed groups were compared using Student's t-test. In cases where data did not follow the normal distribution (Shapiro-Wilks test), comparison was performed using the Mann-Whitney test. The comparison of more than two groups was performed using Kruskal-Wallis test with post hoc Dunn's test. The chi-square test for independence was used to analyse categorical data. The relationship between the changes in levels of psychiatric symptoms (depression, anxiety and stress) and analysed parameters was performed by multiple regression analysis. For categorical data, the coefficients for a specified level were compared with the reference level.

The analysis was performed with the use of statistical package TIBCO Software Inc. (2017). Statistica (data analysis software system), version 13. http://statistica.io. All tests were considered significant at P < 0.05.

The sociodemographic characteristics of the sample are shown in Table 1 . The target group of 564 patients consists of two groups of patients: Among surgical patients who underwent bariatric surgery in Poland, 1 (1.22%) of patients received a gastric balloon, 5 (6.10%) received laparoscopic adjustable gastric banding, 9 (10.98%) received laparoscopic Roux-en-Y gastric bypass and 67 (81.70%) underwent laparoscopic sleeve gastrectomy. Among surgical patients who underwent bariatric surgery in Germany, 40 (54.79%) received a laparoscopic Roux-en-Y gastric bypass and 33 (45.21%) underwent laparoscopic sleeve gastrectomy.

In the groups of patients from both Germany and Poland, most patients were female -75. 24% (Table 2) . Also, a comparative analysis using the Mann-Whitney U-Test revealed that surgically treated patients from Poland and Germany did not significantly differ concerning levels of depression, anxiety and stress symptoms compared with conservatively treated patients (Table 2) . Similarly, at baseline, depression, anxiety and stress levels among surgically treated patients from Poland did not show significant differences compared with surgically treated patients from Germany. The same situation was observed in the case of conservatively treated patients from Poland compared with Germany (Table 2) .

The analysis of data using the Mann-Whitney U-test revealed that after 12 months of active treatment, the general level of depression symptoms significantly decreased from 21 to 14 (Table 2 ) (median decrease 3, P < 0.0001) among Polish patients and showed a highly significant reduction from 22 to 12 (median decrease 7, P < 0.0001) in the Germany patients. A significantly greater change in the level of depression was observed among patients from Germany (P = 0.0005) ( Table 3) .

The analysis of data using the Mann-Whitney U-test revealed that after 12 months of active treatment, among surgically treated patients from both countries, levels of depression symptoms significantly decreased (Poland from 21 to 6, median change 12; Germany from 22 to 4, median change 18). The median change was significantly higher among patients from Germany (P = 0.0065) ( Table 3) . Among conservatively treated patients from both countries after 12 months of active treatment there was a considerable decrease in the level of symptoms of depression (Poland from 21 to 18, median change 2; Germany from 23 to 20, median change 1). There were no significance differences in median change between both groups (Poland compared with Germany).

Analysis of data using the Mann-Whitney U-test revealed that the median shift in the level of depression symptoms among patients from Poland and also from Germany was significantly higher among surgically treated patients compared with conservatively treated patients (Tables 2 and 3) .

Similarly, after the 12 months of active treatment, the general level of anxiety symptoms significantly decreased from 16 to 10 (median decrease 3, P < 0.0001) among Polish patients and showed a highly significant reduction from 17 to 8 (median decrease 6, P < 0.0001) in the Germany patients. A significantly greater change in the level of anxiety was observed among the group of patients from Germany (P < 0.0001).

Analysis of data using the Mann-Whitney U-test revealed that after 12 months of active treatment, among surgically treated patients from both countries, the level of anxiety symptoms significantly decreased (Poland from 15 to 4, median change 11; Germany from 16 to 4, median change 15). Median change was significantly higher among patients from Germany.

Among conservatively treated patients from both countries after the 12 months of active treatment it was observed that there was a significantly decreased level of anxiety symptoms (Poland from 15 to 12, median change 2; Germany from 16 to 10, median change 2). There were no significance differences in median change between both groups (Poland compared with Germany).

Analysis of data using the Mann-Whitney U-test revealed that the median shift in the level of anxiety symptoms among patients from Poland and also from Germany was significantly higher among surgically treated patients compared with conservatively treated patients (Tables 2 and 3) .

Similarly, after 12 months of active treatment, general levels of stress symptoms significantly decreased from 22 to 16 (median decrease 3, P < 0.0001) among Polish patients and showed a highly significant reduction from 23 to 16 (median decrease 6, P < 0.0001) in the German group of patients. Median change in general stress levels did not have significant differences between the analysed group of patients (Tables 2 and 3 ). The analysis of data using the Mann-Whitney U-test revealed that after the 12 months of active treatment, among surgically treated patients from both countries, the level of stress symptoms significantly decreased (Poland from 22 to 8, median change 12; Germany from 22 to 8, median change 14). There were no significance differences in median change between both groups (Poland compared with Germany).

Among conservatively treated patients from both countries after the 12 months of active treatment a significantly decreased level of stress symptoms (Poland from 22 to 18, median change 1; Germany from 23 to 20, median change 1) was observed. There were no significance differences in median change between both groups (Poland compared with Germany). The analysis of data using the Mann-Whitney U-test revealed that the median shift in levels of stress symptoms among patients from Poland and also from Germany was significantly higher among surgically treated patients compared with conservatively treated patients (Tables 2 and 3 ).

The analysis undertaken show no statistically significant differences in the level of perceived depression, anxiety and stress in both the Polish and German patients treated for obesity, depending on the type of bariatric surgery performed (P > 0.05). (Supplementary  Table 1 Additional multiple regression analysis that was performed for confounders that may influence the level of psychiatric symptoms outcome (depression, anxiety and stress) in both groups showed that change in depression symptoms levels were significantly associated with the country, and %TWL. Patients from Germany and with a higher %TWL had the highest decrease in depression symptoms. It was found that change in anxiety symptom levels were significantly associated with the country, gender and %TWL. Patients from Germany, men and with those with higher %TWL had the highest decrease in anxiety symptoms. Similarly, changes in stress symptom levels were significantly associated with country, gender and %TWL. Patients from Germany, men and those with higher %TWL had the highest decrease in stress symptoms. Age, BMI classification, financial situation, and the number of specialists involved in the treatment process do not influence the patient's level of psychiatric symptoms (Table 4 , Supplementary Table 2) .

Among surgically treated patients from Poland, the median %TWL and %EWL was 26 and 64, respectively (Table 5 ). Compared with conservatively treated patients from Poland, median %TWL and %EWL were 5 and 11, respectively. The analysis of data using the Mann-Whitney U-test revealed that median %TWL and %EWL were significantly higher among surgically treated patients compared with conservatively treated patients (P < 0.0001). Similarity among surgically treated patients from Germany median %TWL and %EWL were 28 and 67, respectively. In conservatively treated patients from Germany, median %TWL and %EWL were 7 and 14, respectively. Analysis of data using the Mann-Whitney U-test revealed that median %TWL and %EWL were significantly higher among surgically treated patients compared with conservatively treated patients (P < 0.0001). Additionally, the Mann-Whitney U-test analysis revealed no significant difference in efficacy of the treatment pathways for morbid obesity between both the two groups (Poland versus Germany).

The research results show that the general change in levels of depression, anxiety and stress symptoms because of the method selected for treatment of morbid obesity was significantly greater in patients who were obese living in Germany compared with those in Poland. The general level of psychiatric symptoms after 12 months of active treatment were therefore significantly lower among participants in Germany compared with patients in Poland.

The above situation may result from the fact that there are support groups for patients who are obese in the German obesity treatment centres where the study was conducted. The patient support group for obesity operating at the Charité Hospital in Berlin and the support group working at the Deutsches Rotes Kreuz Hospital in Berlin meet once a month. During the meetings, numerous training sessions are held with experts from various specialties who provide help and support at different stages of obesity treatment. 26 A systematic review and the results of a meta-analyses carried out by Amiri & Behnezhad 27 have shown that anxiety disorders and depressive symptoms occur significantly more often in people who are obese and overweight than among people with a healthy body weight. As a result of the considerably higher level of perceived depressive symptoms among Polish patients, it would be advisable to implement psychological/behavioural therapy as an element of comprehensive obesity therapy. The 'Obesity Balance' therapeutic programme, implemented at the Charité Hospital, also includes psychoeducation on changing patients' behaviour and learning to cope with various emotional situations (anxiety, fear, depression). 26 Psychoeducation undoubtedly reduces the perceived levels of stress, anxiety and depression among patients who are obese and at risk of psychological disorders.

The results of our study conducted in Poland and Germany indicate that bariatric surgery is an effective method for treating obesity. The impact of bariatric surgery on mental health is significantly greater than that from conservative treatment of obesity, in both groups of test participants. The results obtained are consistent with those of other authors. 28 Similar results were obtained in a study conducted by Buddeberg-Fischer et al. 29 The study investigated the physical and psychosocial outcomes of patients who underwent bariatric surgery and those who had not. The surgical group achieved a significantly better result for depression, health perception, social interaction and psychosocial functioning than the conventional treatment group.

Our study results have shown that the quality of mental health among patients with morbid obesity depends significantly on gender and the percentage of total weight loss that has been achieved as a result of treatment. Our results are confirmed by the scientific literature. Most scientific data have shown that improvement in a patient's mental health is likely attributed to weight loss and resultant gains relating to body image, self-esteem and selfconcept. 3 Our study results indicate unequivocally that symptoms of depression and anxiety occur to a greater extent among women who are obese than among men. The above situation applies both to people who are obese and who undergo bariatric surgery and those who receive conservative treatment. Many clinical trials found that obesity is associated with depression; 30,31 the relationship between depression and obesity is likely affected by several confounding factors. One factor that may influence the relationship between obesity and depression is gender. Carpenter et al 32 reported that obesity in women was associated with a 37% increase in the prevalence of major depression. Among men, obesity was associated with a decrease in the prevalence of major depression.

Our study results did not indicate that the type of bariatric surgery performed influenced the perceived levels of depression, anxiety and stress symptoms in patients with obesity from Poland and Germany. In a prospective randomised double-blind trial conducted by Murphy et al, 33 that compared outcomes including weight loss, quality of life, anxiety and depressive symptoms, post-operative complications and mortality after undergoing laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass, it was shown that despite significantly greater weight loss after laparoscopic Roux-en-Y gastric bypass, there were no significant differences in the extent of improvements in either quality of life or in anxiety or depression symptoms between the two types of surgery at 1 year. Our results and the results obtained by Murphy et al 33 are consistent with the results of two previous randomised studies evaluating standard laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy outcomes among patients with obesity and type 2 diabetes. 34, 35 The results of our research showed unequivocally that in both countries, the effectiveness of reducing total and excess body weight was significantly higher with surgical treatment compared with conservative treatment. The obtained results are in parallel with scientific literature. A metal-analysis carried out by Cheng et al 36 based on 25 randomised trials, comprising 1194 participants, revealed a significant advantage among surgical patients rather than those receiving non-surgical treatments (P < 0.05) in terms of primary end-points (weight loss and diabetic remission). Moreover, bariatric surgery was superior to conventional treatment in terms of secondary metabolic parameters. By mechanically altering the physiological mode of gastrointestinal absorption, bariatric surgery triggers a remarkable decline in excessive weight, hyperglycaemia, cardiovascular risk and correlative mortality compared with conservative treatment. 37 Therefore, the updated National Institute for Health and Care Excellence guidance (CG189) in the UK has broadened the indications that as a second-line option, all patients with a BMI >30 should be assessed for bariatric surgery following a lack of response to non-surgical interventions. 38 

The results of our study are innovative as they present one of the first international research reports in the scientific literature of a comparative assessment of the impact of the most commonly used methods for treating obesity (bariatric surgery and conservative treatment) on patient's mental health. In particular, there is a shortage of sufficient research in the field from Poland given the increasing amount of bariatric surgery being performed there. Moreover, the presented data constitute the first scientific report with a comparative analysis of the impact of obesity treatment strategies on patients' mental health in individual European Union countries.

Our study also has some limitations. The most important limitation is that this study sample was recruited from only four international centres from Poland and Germany. It would be very interesting to roll the study out to other centres, for example outside the European Union. Another significant limitation is the relatively short follow-up time of 1 year caused by the COVID-19 pandemic. The length of follow-up between studies varied greatly, examine improve quality of life as an outcome of bariatric surgery in obese adults, ranging from 1 month to 10 years. 7 Generally, studies with a shorter follow-up period are more likely to show significant improvements in mental health. Those with more extended follow-up periods generally demonstrated maintenance of early mental health improvements. 39 In conclusion, bariatric treatment for obesity contributes significantly to an improvement in patients' mental health both in terms of reducing the levels of their depression, anxiety and stress symptoms and reducing body weight compared with a conservative treatment option for obesity. Improvements in mental health as a consequence of treatment were dependent on the specific strategy for treating obesity adopted in the analysed countries, the percentage of total weight loss and on the gender of the patient and it was not dependent on the type of bariatric surgery, their age, BMI, the patient's financial situation or on the number of specialists involved in the treatment process.

Bodymass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies

Obesity and mental health: a longitudinal, cross-cultural examination in Germany and China

Bariatric surgery: mechanisms, indications and outcomes

Evaluation of quality of life in severely obese patients after bariatric surgery carried out in the public healthcare system

Changes in quality of life and body image after gastric bypass surgery

Comparison of the effect of Rouxen-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials

Quality of life outcomes of bariatric surgery: a systematic review

Psychological predictors of weight loss after bariatric surgery: a review of the recent research

Psychological predictors of mental health and health-related quality of life after bariatric surgery: a review of the recent research

The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation

Multi-centre European experience with intragastric balloon in overweight populations: 13 years of experience

Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review

Perceived social support before and after bariatric surgery: association with depression, problematic eating behaviors, and weight outcomes

Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis

White Paper on Obesity

Principles of dealing with overweight and obesity in a family doctor's practice. Family doctor -spe

Evidence-based German guidelines for surgery for obesity

Polish recommendations for bariatric and metabolic surgery

Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample

The Depression-Anxiety-Stress-Scales The DASS -a screening method not only for pain patients

Evaluation of a Polish Version of the Depression Anxiety Stress Scales

Die depressions-angst-stress-skalen: der DASS-ein screeningverfahren nicht nur für schmerzpatienten [depression, anxiety and stress scales: DASS-A screening procedure not only for pain patients

Weight loss reporting: predicted body mass index after bariatric surgery

Height, weight and body mass index references for growth and nutritional status assessment in children and adolescents 3-18 year of age

Referenzperzentile für anthropometrische Maßzahlen und Blutdruck aus der Studie zur Gesundheit von Kindern und Jugendlichen in Deutschland (KiGGS) [Reference percentiles for anthropometric Measurements and blood pressure from the study on the health of children

Cooperation behaviour of primary care paediatricians: facilitators and barriers to multidisciplinary obesity management

Obesity and anxiety symptoms: a systematic review and metaanalysis

Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls

Physical and psychosocial outcome in morbidly obese patients with and without bariatric surgery: a 4 1/2-year follow-up

Body weight and psychological distress in NHANES I

Gender differences in the relationship between personality dimensions and relative body weight

Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study

Laparoscopic sleeve gastrectomy versus banded Rouxen-Y gastric bypass for diabetes and obesity: a prospective randomised double-blind trial

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial

The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and metaanalysis of randomized controlled trials

Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials

Obesity: Identification, Assessment and Management of Overweight and Obesity in Children, Young People and Adults: Partial Update of CG43. National Institute for Health and Care Excellence (UK)

Long-term quality of life following bariatric surgery: a descriptive study

We thank all the contributors for this study. 

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

None Obesity, bariatric surgery, depression, anxiety and stress symptoms